Toll-like receptor 9 is involved in the induction of galectin-9 protein by dietary anti-allergic compound fucoidan

IF 0.9 Q4 IMMUNOLOGY
G. Ezan, M. Mizuno
{"title":"Toll-like receptor 9 is involved in the induction of galectin-9 protein by dietary anti-allergic compound fucoidan","authors":"G. Ezan, M. Mizuno","doi":"10.3934/allergy.2023002","DOIUrl":null,"url":null,"abstract":"Dietary intervention of fucoidan extracted from Saccharina japonica brown seaweed has been ascertained to favor an increase of galectin-9 protein in the intestine of allergic mice, resulting in the attenuation of the food allergy symptoms. The molecular mechanism underpinning that galectin-9 secretion remains unclear. Recently, some evidence has suggested an implication of Toll-like receptor 9 (TLR9) in galectin-9 secretion. However, no investigation has been done. For this study, we aimed to understand the relationship between galectin-9 production and fucoidan intake, which will improve the therapeutic use of fucoidan in allergy treatment. Intestinal epithelial cells (IECs) were cultured in solid or transwell plates and apically exposed to fucoidan solutions and/or synthetic TLR9 agonist (CpG-ODN). The transcriptional response of the cells to galectin-9 (lgals9) and the TLR9 gene was evaluated by using q-RTPCR, and the protein expression of galectin-9 was analyzed by conducting an ELISA test. Knockdown of TLR9 in IECs was performed by targeting TLR9 siRNA, and its effect on galectin-9 release was assessed. We found that the interaction of fucoidan and IECs resulted in the upregulation of galectin-9 released in a dose- and time-dependent manner. The increase was further potentiated in combination with the TLR9 agonist. Fucoidan exposure to IECs tended to increase the mRNA expression of TLR9 in a way similar to that of the TLR9 agonist effect, and knockdown of TLR9 in IECs resulted in a decreased tendency of fucoidan-induced galectin-9 protein. TLR9 activation is therefore involved in the increased release of galectin-9 protein observed in IECs upon fucoidan exposure.","PeriodicalId":40916,"journal":{"name":"AIMS Allergy and Immunology","volume":"1 1","pages":""},"PeriodicalIF":0.9000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"AIMS Allergy and Immunology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3934/allergy.2023002","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Dietary intervention of fucoidan extracted from Saccharina japonica brown seaweed has been ascertained to favor an increase of galectin-9 protein in the intestine of allergic mice, resulting in the attenuation of the food allergy symptoms. The molecular mechanism underpinning that galectin-9 secretion remains unclear. Recently, some evidence has suggested an implication of Toll-like receptor 9 (TLR9) in galectin-9 secretion. However, no investigation has been done. For this study, we aimed to understand the relationship between galectin-9 production and fucoidan intake, which will improve the therapeutic use of fucoidan in allergy treatment. Intestinal epithelial cells (IECs) were cultured in solid or transwell plates and apically exposed to fucoidan solutions and/or synthetic TLR9 agonist (CpG-ODN). The transcriptional response of the cells to galectin-9 (lgals9) and the TLR9 gene was evaluated by using q-RTPCR, and the protein expression of galectin-9 was analyzed by conducting an ELISA test. Knockdown of TLR9 in IECs was performed by targeting TLR9 siRNA, and its effect on galectin-9 release was assessed. We found that the interaction of fucoidan and IECs resulted in the upregulation of galectin-9 released in a dose- and time-dependent manner. The increase was further potentiated in combination with the TLR9 agonist. Fucoidan exposure to IECs tended to increase the mRNA expression of TLR9 in a way similar to that of the TLR9 agonist effect, and knockdown of TLR9 in IECs resulted in a decreased tendency of fucoidan-induced galectin-9 protein. TLR9 activation is therefore involved in the increased release of galectin-9 protein observed in IECs upon fucoidan exposure.
toll样受体9参与饮食抗过敏化合物岩藻糖丹诱导半乳糖凝集素-9蛋白
从日本褐藻中提取岩藻糖聚糖的饮食干预已被确定有利于过敏小鼠肠道中半乳糖凝集素-9蛋白的增加,从而减轻食物过敏症状。半乳糖凝集素-9分泌的分子机制尚不清楚。近年来,一些证据表明toll样受体9 (TLR9)在半乳糖凝集素-9分泌中的作用。然而,没有进行任何调查。在这项研究中,我们旨在了解半乳糖凝集素-9的产生与岩藻糖聚糖摄入量之间的关系,这将改善岩藻糖聚糖在过敏治疗中的治疗应用。肠上皮细胞(IECs)在固体或透孔板中培养,顶端暴露于岩藻聚糖溶液和/或合成TLR9激动剂(CpG-ODN)。采用q-RTPCR检测细胞对半乳糖凝集素-9 (lgals9)和TLR9基因的转录反应,ELISA检测半乳糖凝集素-9的蛋白表达。通过靶向TLR9 siRNA,在IECs中进行TLR9的敲低,并评估其对半乳糖凝集素-9释放的影响。我们发现岩藻聚糖和IECs的相互作用导致半乳糖凝集素-9以剂量和时间依赖性的方式释放上调。与TLR9激动剂联合使用时,这种增加进一步增强。岩藻多糖暴露于IECs后,与TLR9激动剂作用类似,有增加TLR9 mRNA表达的趋势,在IECs中,敲低TLR9导致岩藻多糖诱导的半凝集素-9蛋白有降低的趋势。因此,在岩藻聚糖暴露后,在iec中观察到,TLR9的激活与半乳糖凝集素-9蛋白释放增加有关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
10
审稿时长
4 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信